Susquehanna International Group’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Susquehanna International Group’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,016	Closed	-$584K	–	10970
2019 Q3	$584K	Buy	23,016 +7,668	+50%	+$173K	﹤0.01%	6939
2019 Q2	$331K	Buy	+15,348	New	+$310K	﹤0.01%	8117
2017 Q4	–	Sell	-165,863	Closed	-$3.19M	–	10121
2017 Q3	$3.19M	Buy	+165,863	New	+$3.12M	﹤0.01%	3140

Other funds holding ZEAL

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Susquehanna International Group's ZEAL Position: Q4 2019 in Review

Susquehanna International Group sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q4 2019, closing a stake of 23,016 shares — an estimated $584K sold.

Susquehanna International Group first reported a position in ZEAL in Q3 2017 and held it in 3 quarters. The position peaked at $3.19M in Q3 2017. 17 funds tracked by Wall St. Rank hold ZEAL as of Q4 2019.

Susquehanna International Group reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Susquehanna International Group sold 23,016 Zealand Pharma A/S American Depositary Shares shares in Q4 2019, an estimated $584K.
Susquehanna International Group first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 3 quarters.
Susquehanna International Group's Zealand Pharma A/S American Depositary Shares position peaked at $3.19M in Q3 2017.
17 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2019.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.